Physicians Desk Reference

Physicians Desk Reference, 44th ed.. Medical Economics Co., OradeU, N.., 1990. 

Medical Economics Co., Physicians Desk Reference for Nonprescription Drugs, Van Nostrand Reiohold, New York, 1991. 

Physicians Desk Reference distributed by Thomson Scientific, http //scientific. thomson.com/products/pdr. 

Physicians Desk Reference. Medical Economics Company, Montvale, New Jersey 1997. 

Physicians Desk Reference Use-in-Pregnan-cy Ratings, ed 58. Montvale, Medical Economics Company, 2004. 

Sifton, D.W. ed. PDR Guide to Biological and Chemical Warfare Response. Montvale, NJ Thompson/Physicians Desk Reference, 2002. 

Physicians Desk Reference, 31st Ed., Medical Economics Inc., Oradell, NJ, p. 890 (1977). 

Physicians Desk Reference, 55th ed. Montvale, NJ Medical Economics Company... 

Cohen, J.S. (2001). Dose discrepancies between the Physicians Desk Reference and the medical literature and their possible roles in the high incidence of dose-related adverse drug events. Archives of Internal Medicine 161 957-964. 

The demonstration of genotoxic activity in a pharmaceutical molecule may not necessarily translate into discontinuation of development and ultimate licensing of the product to be marketed. A survey of the Physicians Desk Reference reveals many examples of pharmaceutical products that have been shown to elicit genotoxic activity in one or more gene-tox assays.41 This observation indicates that other factors (such as risk, benefit, seriousness of ailment, target patient population, dosage, and frequency of administration, among others) are taken into consideration. 

PDR. 1991. Physicians Desk Reference. 45th ed. Oradell, NJ Medical Economics Data, 2358-2359. 

Physicians Desk Reference, 62nd edn. Thomson PDR, Montvale, NJ, 2008 this publication is updated annually www.PDR.net. 

For a detailed description of orlistat and its approved uses (or for any other prescription medication approved for sale in the United States), see The Physicians Desk Reference. 

---